“…However, SIADH has been reported to occur after the initiation of chemotherapy reflecting tumor lysis and a massive release of ADH. SIADH is most frequently associated with small-cell lung cancer, but may also occur in association with a variety of other carcinomas arising in the brain, prostate, bladder, pancreas, adrenal cortex, duodenum, head, and neck, and with mesothelioma, thymoma, sarcoma, peripheral T-cell lymphoma, anaplastic large cell lymphoma, acute myelomonocytic leukemia, and Hodgkin's disease [1,[6][7][8][9][10][11][12][13][14][15]. Although the clinical data in these studies was compatible with the diagnosis of SIADH, it was not confirmed by immunohistochemical techniques.…”